Elliott Bennett-Guerrero is a professor of anesthesiology currently serving Duke University in Durham, North Carolina. Additionally, Elliott Bennett-Guerrero acts as director of perioperative clinical research at the Duke Clinical Research Institute, where he leads extensive research projects examining issues regarding blood transfusion during coronary artery bypass surgery.
Patients diagnosed with severe coronary heart disease may be recommended for a type of open heart surgery known as coronary artery bypass graft, or CABG, surgery. During the procedure, the surgeon grafts a healthy artery from another location within the body, usually the chest or leg, and binds it to the blocked coronary artery, so as to bypass the blocked portion of it. This rerouting allows blood to flow freely to the heart. CABG surgery may be performed on more than one blocked coronary artery at a time. CABG is effective in reducing angina and strengthening the pumping action of a weakened heart. Although repeat surgery may be necessary over time for some patients, the majority report a reduction or elimination of symptoms and a significantly improved quality of life.
0 Comments
A professor of anesthesiology at Duke University, Dr. Elliott Bennett-Guerrero has nearly two decades of experience. Dr. Elliott Bennett-Guerrero also serves as the director of perioperative clinical research within the Duke Clinical Research Institute.
In October 2014, the Duke Clinical Research Institute (DCRI) announced its participation in a five-year project to study the effectiveness of various treatments for uterine fibroids in women. Collaborating with the Agency for Healthcare Research and Quality and the Patient-Centered Outcomes Research Institute, DCRI serves as the project coordinator and lead on the $20 million project. Their involvement falls in line with the institute’s existing fibroids treatment research that spans more than a decade. Evan Myers, MD, MPH, of the Duke University School of Medicine Department of Obstetrics and Gynecology and the DCRI, leads the initiative along with several others. He and the rest of the team members are responsible for reporting the demographics for female patients who received uterine fibroids treatments and recording their response to the medication. To learn more about the Duke Clinical Research Institute, visit www.dcri.org. |
AuthorDr. Elliott Bennett-Guerrero is both an educator and a vice chairman at Stony Brook Medicine. Archives
June 2022
Categories
All
|